COVID-19 and hydroxychloroquine: Is the wonder drug failing?

Eur J Intern Med. 2020 Aug:78:1-3. doi: 10.1016/j.ejim.2020.06.002. Epub 2020 Jun 4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antimalarials / administration & dosage
  • Antimalarials / adverse effects
  • Betacoronavirus / drug effects
  • COVID-19
  • COVID-19 Drug Treatment
  • Clinical Trials as Topic
  • Coronavirus Infections* / drug therapy
  • Coronavirus Infections* / epidemiology
  • Drug-Related Side Effects and Adverse Reactions* / etiology
  • Drug-Related Side Effects and Adverse Reactions* / prevention & control
  • Humans
  • Hydroxychloroquine* / administration & dosage
  • Hydroxychloroquine* / adverse effects
  • Long QT Syndrome* / chemically induced
  • Long QT Syndrome* / prevention & control
  • Observational Studies as Topic
  • Pandemics*
  • Pneumonia, Viral* / drug therapy
  • Pneumonia, Viral* / epidemiology
  • SARS-CoV-2

Substances

  • Antimalarials
  • Hydroxychloroquine